Back
HFA Premium Access

Metabolic impact of empagliflozin in patients with acute decompensated heart failure:A secondary analysis of the EMPAG-HF trial

Session: Acute heart failure - pharmacotherapy
Topic: Pharmacotherapy
Speaker: Doctor J. Bogoviku (Jena, DE)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Jurgen Bogoviku

University hospital Jena, Jena (Germany)
1 presentation
0 follower

5 more presentations in this session

Association between dose of medications and mortality in heart failure with reduced ejection fraction: a systematic review and dose-response meta-analysis

Speaker: Doctor D. Rodolico (Pisa, IT)

Access
Abstract
Slides
Like
Thumbnail

Effect of SGLT-2 inhibitors on weight loss in HFrEF and HFpEF patients: meta-analysis of 14 thousand participants

Speaker: Doctor A. Sunjaya (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Benzodiazepines in patients with acute heart failure: a propensity score matching study

Speaker: Doctor P. Salamanca Bautista (Seville, ES)

Access
Abstract
Slides
Like
Thumbnail

Pharmacotherapy modifications in acute heart failure

Speaker: Mr J. Stevancec (Murska Sobota, SI)

Access
Abstract
Slides
Like
Thumbnail

Hypertonic saline in the management of refractory congestion in decompensated heart failure

Speaker: Doctor C. Saldarriaga Giraldo (Medellin, CO)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Acute heart failure - pharmacotherapy

Speakers: Doctor J. Bogoviku, Doctor D. Rodolico, Doctor A. Sunjaya, Doctor P. Salamanca Bautista, Mr J. Stevancec...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources